# Vaccine Therapy in Treating Patients With Stage D0 Prostate Cancer

> **NCT00514072** · PHASE2 · UNKNOWN · sponsor: **Kael-GemVax Co., Ltd.** · enrollment: 54 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** BCG vaccine
- **BIOLOGICAL:** prostate cancer vaccine ONY-P1
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00514072
- **Lead sponsor:** Kael-GemVax Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-03
- **Primary completion:** 2012-09
- **Final completion:** —
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2012-08-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00514072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00514072, "Vaccine Therapy in Treating Patients With Stage D0 Prostate Cancer". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00514072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*